Predictive Oncology Inc. (NASDAQ: POAI) Reports 58% Revenue Increase; Notes Business Highlights for Q3 2019
POAI sees Q3 2019 revenue total $522,696 from $329,930 in Q3 2018 Company reports records sales of proprietary systems, supplies Significant business highlights indicate continued momentum as Predictive Oncology looks to bright future Predictive Oncology Inc. (NASDAQ: POAI), an artificial intelligence (AI) and data-driven functional precision medicine company, released its financial results for Q3 2019, and the numbers are impressive, including quarter revenues increasing 58% year over year (http://ibn.fm/TmZoV). The company also provided a business update outlining significant highlights reached during the quarter. POAI reported that revenue for the quarter ended September 30, 2019, totaled $522,696, compared with $329,930 for the same period of…